feed,title,long_url,short_url
MedRxiv,Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals,https://medrxiv.org/cgi/content/short/2022.04.30.22274189v1?rss=1,https://bit.ly/3LCuFiE
MedRxiv,Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study,https://medrxiv.org/cgi/content/short/2022.04.28.22274402v1?rss=1,https://bit.ly/380r8fl
MedRxiv,"Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study",https://medrxiv.org/cgi/content/short/2022.04.29.22274387v1?rss=1,https://bit.ly/3KCz7wg
MedRxiv,"Epidemiological and clinical features of SARS-CoV-2 Infection in children during the outbreak of Omicron Variant in Shanghai, March 7-March 31, 2022",https://medrxiv.org/cgi/content/short/2022.04.28.22274421v1?rss=1,https://bit.ly/3OLz8S5
